“Smart” Leadership in Technology, “Wei” Innovation for the Future | Zhongou Zhiwei (Shanghai) Robotics Co., Ltd. Grand Opening

Sino-European Zhiwei (Shanghai) Robotics Co., Ltd. is a joint venture established by Ningbo Huake Run Biotechnology Co., Ltd. and the European innovative surgical robotics company Interventional Systems (INS). The company is dedicated to the innovative R&D and commercialization of digital orthopedic products and microsurgical robotic technologies. The surgical robot that Sino-European Zhiwei is about to launch boasts distinctive features and advantages, including a compact footprint, user-friendly operation, rapid performance, high cost-effectiveness, and ease of widespread adoption. It is suitable for a range of applications, including spinal internal fixation surgery, spinal interventional procedures, percutaneous endoscopic spine surgery, and sports medicine procedures. The company aims to develop an internationally leading, China-made smart product that provides comprehensive micro-robotic surgical assistance solutions for clinical practice and the market.

At 11:18 a.m., the ceremony officially commenced, with the venue brimming with distinguished guests and a sea of esteemed attendees. A dazzling performance by dance robots, set to rhythmic and dynamic music, not only showcased the captivating allure of cutting-edge technology but also marked the grand opening of Zhongou Zhiwei (Shanghai) Robotics Co., Ltd.

Following a vibrant opening performance, Mr. Ma Yan, the company’s General Manager, took the stage to deliver a speech. He extended his heartfelt gratitude to the guests in attendance and to all those who had offered support and care throughout the preparation of Sino-European Zhiwei, while expressing full confidence in the company’s future development: Huake Run is committed to building an innovative, robot-enabled platform enterprise for minimally invasive orthopedic surgery. The establishment of Sino-European Zhiwei (Shanghai) Robot Co., Ltd. will seamlessly integrate robotic systems with consumable products, fully leveraging the strengths of both Chinese and European partners in terms of products and technology, thereby bringing highly innovative and cost-effective robot-assisted surgical solutions to the Chinese market.

Mr. Chen Xinxing, Executive Director of Hillhouse Capital, stated in his address: “The establishment of Zhongou Zhiwei’s national innovation and technology center in Shanghai lays a solid foundation for the company’s long-term development. Hillhouse will work closely with the company’s management team to move forward, and through sustained resource investment, we will jointly promote the advancement of surgical robotics in China and drive the Chinese healthcare industry toward minimally invasive, digital, and intelligent transformation.”

Mr. Michael Vogele, CEO of Interventional Systems (INS), also sent a video message from the other side of the globe. His team has long been committed to developing miniaturized, minimally invasive robotic solutions, and INS is eagerly looking forward to collaborating with domestic R&D teams to introduce a new generation of products to the Chinese market that will make surgery more precise, faster, more effective, and safer, thereby delivering superior clinical outcomes. Mr. Vogele expressed strong confidence in the partnership between the two companies, believing that the future prospects for Zhongou Zhiwei are truly limitless.

Following the guest speeches, at the invitation of General Manager Mr. Ma Yan, the distinguished guests took to the stage to cut the ribbon, officially inaugurating Zhongou Zhiwei. Specially crafted mechanical gloves for the ribbon-cutting ceremony symbolized Zhongou Zhiwei’s commitment to independent innovation and bold pioneering, while service robots presented each guest with a pair of scissors. Amidst thunderous applause and cheers, the atmosphere reached its peak as the guests jointly cut the ribbon for Zhongou Zhiwei (Shanghai) Robot Co., Ltd., marking the successful conclusion of the opening ceremony and ribbon-cutting event!

China’s orthopedic minimally invasive field is now experiencing unprecedented rapid development and innovation. The official establishment of Sino-European Zhiwei (Shanghai) Robotics Co., Ltd. marks a solid step forward for Ningbo Huake Run and INS in the areas of digital orthopedic products and microsurgical robots. “Zhi” leads technology, and “Wei” creates the future—Sino-European Zhiwei will respond to the national call to vigorously advance the “Made in China 2025” strategy and the upgrade toward intelligent manufacturing. Leveraging the R&D expertise of both partners, adhering to a pragmatic approach to development, pioneering successful business models, and continuously infusing innovative elements, the company will bring more diverse concepts and sustained momentum to the fields of orthopedic minimally invasive surgery and surgical robotics, igniting passion with vision and shaping the future through technology.